FENC

Fennec Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality7/10
  • Growth↓ 0/10
  • Momentum↑ 6/10
Fennec Pharmaceuticals sales and earnings growth
FENC Growth
Low
  • Revenue Y/Y↓ -21.39%
  • EPS Y/Y↓ -525.00%
  • FCF Y/Y↓ -133.84%
Fennec Pharmaceuticals gross and profit margin trends
FENC Profitability
Fair
  • Gross margin ↑ 93.10%
  • EPS margin↓ -17.90%
  • ROIC↓ -11.40%
Fennec Pharmaceuticals net debt vs free cash flow
FENC Risk
Great
  • Debt / Equity↓ -4.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -1.4

Fennec Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗